30th Annual GP2A Medicinal Chemistry Conference-Reference-Cited by-同舟云学术

30th Annual GP2A Medicinal Chemistry Conference

Published:2023-03-12 Issue:3 Volume:16 Page:432
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

O’Boyle Niamh M.¹^ORCID,Helesbeux Jean-Jacques²^ORCID,Meegan Mary J.¹^ORCID,Sasse Astrid¹^ORCID,O’Shaughnessy Elizabeth¹,Qaisar Alina¹,Clancy Aoife¹,McCarthy Florence³^ORCID,Marchand Pascal⁴^ORCID

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences, Panoz Institute and Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland

2. Department of SONAS, Université Angers, SONAS, SFR 4207 QUASAV, F-49000 Angers, France

3. School of Chemistry and ABCRF, University College Cork, T12 K8AF Cork, Ireland

4. Cibles et Médicaments des Infections et de l’Immunité, IICiMed, Nantes Université, UR 1155, F-44000 Nantes, France

Abstract

The Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A) held their 30th annual conference in August 2022 in Trinity College Dublin, Ireland. There were 9 keynote presentations, 10 early career researcher presentations and 41 poster presentations.

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://www.mdpi.com/1424-8247/16/3/432/pdf

Reference203 articles.

1. HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases;Yoon;Chonnam Med. J.,2016

2. Targeting Class I Histone Deacetylases in a “Complex” Environment;Millard;Trends Pharmacol. Sci.,2017

3. Smalley, J.P., Cowley, S.M., and Hodgkinson, J.T. (2020). Bifunctional HDAC Therapeutics: One Drug to Rule Them All?. Molecules, 25.

4. PROTAC-mediated degration of class I histone deacetylase enzymes in corepressor complexes;Smalley;Chem. Commun.,2020

5. Cowley, S.M., Hodgkinson, J., Schwabe, J., Cross, J., Smalley, J., Grace, A., and Millard, C. (2021). HDAC Degrdaer. (WO2021GB50156), WIPO PCT Application Number.